| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,056 |
9,946 |
$681K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,297 |
1,297 |
$116K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,948 |
1,832 |
$41K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
431 |
420 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
342 |
335 |
$28K |
| 87428 |
|
398 |
392 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
426 |
423 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
250 |
241 |
$11K |
| 99051 |
|
1,616 |
1,574 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
402 |
378 |
$8K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
979 |
944 |
$5K |
| 86328 |
|
91 |
88 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,563 |
1,462 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
129 |
129 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
109 |
107 |
$467.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,100 |
1,057 |
$463.36 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
15 |
$452.61 |
| 81001 |
|
134 |
129 |
$421.37 |
| 99442 |
|
17 |
15 |
$279.97 |
| 87807 |
|
14 |
13 |
$170.38 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
13 |
$71.23 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$18.08 |